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Pain should be assessed and managed as an early priority, once the ABCs
(Airway, Breathing, Circulation) have been managed, allowing greater precision
in further management. Pain is often difficult to measure in an emergency situa-
tion, and the usual assessment tools are more relevant to chronic pain. However,
factors such as anxiety level and the patient’s personality are important. 
In an emergency pain is assessed rapidly using both verbal and behavioural
cues. Pain is clearly a parameter of clinical need that deserves attention sooner
rather than later, and looking at ‘incident to analgesia time’ may reduce the time
taken to provide pain management. This could also include ‘incident to spinal
board time’, ‘incident to comfort time’. Pain can be graded as none, mild, mod-
erate, and severe.
Early analgesia will reduce the neuro-endocrine response to stress, which pro-
duces an increase in adrenocorticotrophic hormone (ACTH), cortisol, antidiuretic
hormone (ADH), growth hormone (GH) and glucagon. The stress response
reduces insulin uptake, causing hyperglycaemia, relative glucose intolerance and
insulin resistance, and promotes catabolism of proteins and lipids. Pain produces
sympathetic hyperactivity, resulting in an increase in heart rate, stroke volume,
and myocardial oxygen consumption, and a decrease in gastrointestinal motility
and urine output. Factors that drive this stress response are anxiety, pain, hypo-
/hyperthermia, acidosis, starvation, dehydration, hypoxia, infection, and pro-
longed immobilisation.
What distresses patients? The following were found in patients who had been
through an emergency unit and then been admitted to an intensive care unit:
pain, anxiety, lack of rest, thirst, endotracheal intubation, nasogastric intubation,
intravenous cannulation, urinary catheterisation, lying on a spinal board, ill-fitting
cervical spine collars, feeling cold, and poor communication. All of the above
are part of the pre-hospital and emergency unit environment. The pre-hospital set-
ting may include extrication after entrapment, splinting of fractured limbs, and
other unpleasant procedures.
Analgesic requirements can be reduced by attending to simple matters first.
Effective, confident communication with the patient and attending staff (both nurs-
ing and paramedic) will create an atmosphere of trust and co-operation that will
facilitate management. Measures that will reduce the amount of analgesia
required are cooling and covering burns, cooling muscle injuries, elevating,
splinting and immobilising an injured limb. Sedation should be considered once
adequate analgesia is achieved as pain relief should allay much of the patient’s
anxiety. 
DRUG ADMINISTRATION 
A variety of routes for administering analgesia are needed in an emergency. The
gold standard is the intravenous route — as it is the most efficient and direct, the
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drug can be titrated, and can be
given intermittently or continuously.
Other routes of administration are use-
ful under varying circumstances. The
intramuscular route is discouraged
except in the case of an unco-opera-
tive/aggressive patient, because
absorption rates are unpredictable.
The oral route is useful in patients who
have been triaged as category green
(priority three) and are assessed as
having mild to moderate pain. These
will benefit from paracetamol,
codeine, or paracetamol/codeine
combinations. Sublingual lorazepam is
very effective for moderately anxious
individuals. 
The intranasal route is convenient and
safe, and an attractive alternative to
parenteral administration, and is the
route of choice in children for mor-
phine and midazolam. Ketamine some-
times causes a mild burning/unpleas-
ant taste, but is accepted by the
majority of children.1,2 The rate and
extent of absorption, and plasma con-
centrations, are comparable with intra-
venous drug administration. The atom-
ised pump is the best nasal delivery
system, due to good mucosal distribu-
tion of the drug. The bioavailability of
midazolam with an atomiser is 83%,
compared with 50% when using a
dropper. The bioavailability of opioids
and ketamine with an atomizer is
approximately 50% — ketamine via
the rectal route has a bioavailability of
25%. Naloxone has a bioavailability
of close to 100% via an atomiser.
Limiting factors include a blocked,
infected, traumatised, painful or bleed-
ing nose. 
Although the endotracheal route is sel-
dom used, it can be used for selected
drugs, e.g. naloxone. For adults, dou-
ble the dose of the drug and follow
with a 10 ml saline or water flush. The
rectal route can be used for benzodi-
azepines, paracetamol, and non-
steroidal anti-inflammatory drugs,
especially in unco-operative paediatric
patients.
Analgesia is sometimes withheld, or
administered in inappropriate doses
due to ignorance and/or misinforma-
tion. Patients with head injuries should
be given adequate analgesia to
reduce raised intracranial pressure
caused by pain. Patients with acute
abdomens should receive good anal-
gesia. This aids the surgeon’s assess-
ment and investigation. Patients with
fractured ribs and contused chest walls
should be given intercostal or
haematoma blocks at the site of injury,
rather than large doses of opioids with
the risk of further respiratory depres-
sion.
ANALGESIC  DRUGS
Get to know a few drugs very well,
rather than knowing too little about
many drugs that are not used regular-
ly. I have limited my discussion to
drugs that are regarded as ‘need to




The ‘king’ of the opioids has two main
metabolites — 85% of the drug is
metabolised to anti-analgesics, 10% is
metabolised to a chemical that is 40%
more potent than morphine. Patients
with compromised liver function should
be given fentanyl in preference to mor-
phine, as fentanyl has no metabolites.
However fentanyl is nauseating, espe-
cially if given orally to children.3
Recommended administration of
morphine
Dilute10 mg in normal saline/water to
a 1:10 dilution (1 ml = 1 mg), admin-
ister 0.1 mg/kg intravenously as a
slow bolus over 1 minute, as a ‘load-
ing’ dose. Reassess after 10 minutes,
add (titrate)1 - 2 mg aliquots at 
5-minute intervals until satisfactory
pain relief.4 Nausea caused by mor-
phine is related to the concentration of
the drug and rapidity of administra-
tion. If morphine is given as suggest-
ed, metoclopramide is not needed rou-
tinely.5 Morphine combined with
cyclizine (cyclimorph) is not advised,
as the cyclizine may limit the dosage
of morphine that can be given. 
The intranasal route requires the same
‘loading dosage’ (0.1 mg/kg).6 The
appropriate dose is drawn up in a 1
ml (or 2 ml) syringe and attached to
an atomiser. Half the volume is given
in each nostril, aiming the nozzle pos-
teriorly, and asking the child to sniff
during and after administering the
drug. Onset of action is approximately
5 - 10 minutes. Aliquots of  0.5 mg
may be given later if required, until
satisfactory analgesia is achieved
without risking respiratory depression.
Fig. 1 demonstrates a 1 ml syringe
being used with an atomiser. 
Tramadol (Tramal)
This is an opioid with intermediate 
efficacy. It is used pre-hospital and in-
hospital. It produces less respiratory
depression than morphine. Rapid
bolus administration causes flushing,
nausea and sweating. 100 mg tra-
madol =10 mg morphine.
Nalbuphine (Nubain)
Nalbuphine is used largely in the pre-
hospital setting by paramedics. It acts
as a partial opioid antagonist, and
when subsequent doses of morphine
are administered, larger doses than
usual will be required to achieve the
desired effect; it is for this reason that
hospital practitioners should be aware
of this drug. Nalbuphine is registered
in South Africa, but is currently not
commercially available.
Tilidine (Valoron)
This drug is effective when given sub-
lingually, provided it is in the correct
dosage. The previously recommended
dosage of 1 drop per year of age is
inadequate, and a dose of 1 mg/kg 
(1 drop = 2.5 mg) is more appropri-
ate. Overdose may cause convulsions.
Fig. 1. A 1 ml syringe used with an 
atomiser.
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Codeine
Codeine is a low efficacy opioid. It is
useful to have codeine tablets avail-
able for patients who have mild to
moderate pain, have been triaged as
‘green’, and may have some time to
wait before they are attended to by a
doctor. Combination tablets containing
codeine and paracetamol are very
effective — 20 mg codeine plus 500
mg paracetamol is available as
Empacod.  For patients who cannot
tolerate codeine, paracetamol should
be available.  
Opioid antagonism
The opioid antagonist naloxone
(Narcan) must be available wherever
opioids are administered. The neona-
tal preparation should not be used as
it is too dilute. Use only the full
strength (0.4 mg/ml) preparation.
Naloxone reverses both the analgesic
and respiratory depressant effects of
opioids. The contents of an ampoule
should be diluted 1:10 with
water/normal saline, and an initial
dosage of 0.2 mg given intravenously.
After 3 minutes, further aliquots of 0.1
mg should be given (titrated) until the
desired effect is achieved. This will
reduce respiratory depression, while
minimising the reduction in pain relief.
Naloxone acts for 30 - 45 minutes,
which is significantly shorter than the
action of most opioids (other than fen-
tanyl). It may therefore be necessary
to set up an infusion by adding 8.0
mg to 200 ml normal saline and infus-
ing at a rate of 25 ml/hour.   
Entonox 
A mixture of 50% nitrous oxide and
50% oxygen is available in cylinders;
patients can self-administer using a
demand valve that is triggered by
forceful inhalation. It should be avail-
able in the pre-hospital setting as well
as in emergency units. It is a conven-
ient, effective, and safe analgesic that
is underutilised in emergencies in
South Africa. However, certain precau-
tions and contraindications must be
taken into account. At 6°C the nitrous
oxide and oxygen separate and an
anoxic gas mixture may be delivered.
The contraindications are related to
nitrous oxide diffusing more rapidly
than nitrogen. They include undrained
pneumothorax, post-SCUBA diving





In general NSAIDs should be avoided
in compromised patients, as they
impair renal perfusion, and cause
retention of sodium and fluid. Giving
NSAIDs to a dehydrated patient
increases the risk of renal damage.
Many emergency doctors agree that
NSAIDs should be reserved for 24
hours post-stabilisation, when renal
perfusion/function would most likely
have returned to normal. This includes
the newer intravenous NSAIDs.
Diclofenac eye drops are useful for
corneal abrasions, superficial
corneal/scleral lacerations, and post-
corneal foreign body removal.
SEDATION IN THE
EMERGENCY ENVIRONMENT
Some patients may require sedation
without analgesia in an emergency,
for example in situations such as the
sudden death of a loved one. The
most appropriate drug is sublingual
lorazepam, given as a 1 mg tablet (up
to a maximum of 4 mg).
The benzodiazepines are the favoured
group of drugs for sedation after anal-
gesia has been given. Emergency
environment terminology of sedation
may be confusing and inappropriate.
Conscious sedation, monitored anaes-
thetic care, and dissociate anaesthesia
are all anaesthetic terms. Procedural
sedation is a more appropriate term
and has been recommended by the
American College of Emergency
Physicians. The definition of conscious
sedation may be used to describe pro-
cedural sedation: a drug-induced
depression of consciousness during
which patients respond purposefully to
verbal commands, either alone or
accompanied by light tactile stimula-
tion. No interventions are required to
maintain a patent airway, and sponta-
neous ventilation is adequate.
Cardiovascular function is maintained.
If left undisturbed the patient may fall
asleep, but is easily aroused by audi-
tory or tactile stimuli. Protective airway
reflexes are intact.7,8
Synergism between opioids and ben-
zodiazepines is both positive and neg-
ative in implication:
Analgesia + sedation = procedural
sedation 
1 + 1 (should) = 2
If  the synergistic action is not under-
stood/anticipated, this could be seen
as:
Opioid + benzodiazepine  = 
respiratory depression 
OR
1 + 1 = 3    
Good practice could be seen as:
1 + 1/2 = 2       
Benzodiazepines
The benzodiazepines are divided into
short-acting, intermediate-acting and
long-acting drugs. Emergency doctors
should get to know one of each cate-
gory.
Midazolam (Dormicum)
This short-acting benzodiazepine is 2 -
3 times more potent than diazepam,
and is available in three strengths.
Keep only one strength in the emer-
gency unit — 5 mg/5 ml. This will
minimise dosing errors and allow
familiarity with a consistent concentra-
tion of the drug. Midazolam is well
known for its idiosyncratic effects. It
has active metabolites, and can accu-
mulate. Its duration of action is
approximately 45 minutes. The adult
loading dose is 2 mg intravenously
over 30 seconds. The maximum effect
is in 3 minutes. After 3 minutes, incre-
ments of 1 mg can be given every 3
minutes until the desired effect is
achieved. Common errors are made
by not waiting the full 3 minutes
before administering further drug,
which may cause respiratory depres-
sion. Elderly patients should be given
half of the above-recommended
dosage. Children can be given mida-
zolam orally, rectally, intranasally, or
intravenously. The paediatric doses
are as follows: intranasal 0.4 mg/kg,
oral/rectal 0.5 mg/kg,  intravenous
0.1 mg/kg. 
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and managed as an early




Measures that will reduce
the amount of analgesia





The intramuscular route is
discouraged except in the




The intravenous dose is an anaesthetic
induction dose, so when using intra-
venous midazolam after the child has
had morphine, halve the dosage and
continuously monitor oxygen satura-
tion. The intranasal route has several
advantages and is effective in 5 - 10
minutes. In the fitting child, midazolam




azepine which has no metabolites.
The 1.0 mg sublingual tablets and the
4 mg/ml ampoules should be avail-
able, and are useful in acute anxiety,
acute psychosis, alcohol withdrawal,
and status epilepticus. The maximum
safe adult dosage is 4 mg, and the
minimum effective dose should be
titrated to the individual patient’s
needs. The intravenous dose for chil-
dren is 0.1 mg/kg. However, if admin-
istered after an opioid this dose
should be halved. 
Diazepam (Valium)
A long-acting benzodiazepine which
is less potent than the previous two. It
has active metabolites, and a scleros-
ing effect on veins. The intravenous
dosage of 0.1 mg/kg applies to both
adults and children, and the rectal
dosage is 0.5 mg/kg.
The benzodiazepine
antagonist — flumazenil
Flumazenil binds competitively to ben-
zodiazepine receptors and reverses
the central sedative effects of benzodi-
azepines. The adult dose is 0.2 mg.
After 2 minutes further increments of
0.1 mg can be given every minute
until the desired effect is achieved. If
an intermediate- or long-acting benzo-
diazepine has been given, start an
infusion of flumazenil — 1.0 mg in
200 ml normal saline at a rate of 50
ml/hour.
Barbiturates 
Phenobarb and phenytoin are second-
line drugs for status epilepsy in
patients who have not responded to a
second dose of a benzodiazepine.
They are also used prophylactically in
patients with head injuries who are at
high risk of fitting (depressed skull
fracture, localised cortical injury, sub-
dural haematoma). 
Phenobarbitone is very viscous and
should be given as a slow bolus over
1 - 2 minutes at the site of the intra-
venous cannula. If it is injected into
the giving set it may settle in the tub-
ing and not flow into the patient. The
loading dosage is 18 mg/kg.
The phenytoin (Epanutin) loading dose
infusion of 18 mg/kg needs to be run
in over 30 minutes, which is not effi-
cient in seizure control as it takes 30
minutes before therapeutic levels of the
drug are reached. The advantage of
its use in patients with head injuries is
that it has little effect on level of con-
sciousness. Phenytoin is incompatible
with glucose solutions, and will form a
solid mass if mixed with 5% glucose.
Hypotension and respiratory depres-
sion are disadvantages. Subcutaneous
extravasation has been known to
cause skin necrosis. 
OTHER SEDATIVE DRUGS
Haloperidol (Serenace) 
This is the drug of choice for delirium,
and is a useful adjunct to lorazepam
in the management of agitated,
aggressive, psychotic states. The adult
intramuscular/intravenous dose is 5.0
mg. This may be given after 4 mg of
lorazepam if this has not worked with-
in 15 - 20 minutes. Extrapyramidal
effects (dystonia, akathisia) of
haloperidol can be treated with biperi-
den (Akineton) 2 mg slow IV and this
dose may be repeated to a maximum
of 8 mg. Analgesic requirements may
then be assessed, and an appropriate




This new drug will probably be avail-
able in South Africa during the course
of 2004. It has both anxiolytic and
analgesic properties. It does not cause
respiratory depression, and patients
maintain cognition and are easily
rousable. The bradycardia and
hypotension that are produced and the
delay in onset of analgesia (1 hour)




Ketamine is well known for producing
dissociative anaesthesia and is useful
in an emergency. It is a safe, reliable
and predictable drug, with potent
analgesic properties and patients can
maintain their own open airway. It
also has a bronchodilatory effect, and
increases the pulse rate and blood
pressure. Atropine is sometimes used
in conjunction with ketamine because
of the increase in salivation and
lacrimation, but I have not found this
necessary. Laryngospasm has been
reported, but is due to secretions
draining onto the vocal cords and not
to the drug per se. Positioning the
patient so that saliva can drain out of
the mouth should prevent this.
Benzodiazepines, opioids, and local
anaesthetic agents are compatible and
safely used with ketamine.9-14 Contra-
indications include hypertension,
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recent myocardial infarction, head
injury/raised intracranial pressure,
and psychiatric conditions.
In the pre-hospital environment keta-
mine may facilitate procedures carried
out before extricating entrapped
patients. Adults require a benzodi-
azepine before ketamine, to reduce/
eliminate emergence phenomena
which include excitation and hallucina-
tion. Cannulate the patient, and initial-
ly give adults 5.0 mg diazepam intra-
venously 5 minutes before the intra-
venous induction dose of ketamine —
2 mg/kg over 1 minute. Procedural
sedation occurs within 1 minute, and
the duration of action is approximately
10 minutes. A further maintenance
dose may be required. This should be
50% of the induction dose. Further
small (1 - 2 mg) increments of
diazepam can be given, tailored to
the needs of the patient.
In the emergency unit ketamine can
help the successful management of
painful procedures on children, who
do not experience emergence phenom-
ena to the same extent as adults and
so do not usually need a benzodi-
azepine as well. After a sub-anaesthet-
ic dose of 2.0 mg/kg intramuscularly,
the drug is effective in 5 - 6 minutes
and allows 15 - 20 minutes in which
to complete the procedure. Ketamine
has been used intranasally at a
dosage of 5 mg/kg and it is reported
to produce a burning sensation and a
bitter taste. It may also be adminis-
tered orally, by mixing in a cooldrink,
at a dosage of 6 mg/kg when the
drug is used alone, or at a lower
dosage of 3 mg/kg when used in con-
junction with a benzodiazepine or an
opioid. Nausea and vomiting associat-
ed with ketamine is reported in 14%
of paediatric patients. 
Ketamine/midazolam
The following dosages are advised
when using these two drugs in combi-
nation for paediatric procedural seda-
tion:
• intravenous route — ketamine 
1 mg/kg, midazolam 0.01 mg/kg
• oral route — ketamine 3 mg/kg,




The responsible doctor should have
passed the three Advanced Life
Support courses and have anaesthetic
experience, and should be assisted by
a professional nurse trained in moni-
toring vital signs. The patient must be
on a surface that can be tilted, and if
sedation is performed without intra-
venous access, then equipment for vas-
cular access must be immediately
available. Suction apparatus, oxygen,
oropharyngeal airways, bag/valve/
mask, endotracheal tubes, and a
laryngoscope must be at hand. The
patient must be connected to a car-
diac monitor, and oxygen saturation
must be measured during and after the
procedure until it is thought safe to dis-
continue monitoring. Prior to dis-
charge, the patient should be able to
speak normally and walk with assis-
tance.
Sedation for intubation
So-called rapid sequence intubation
should be a controlled procedure
under the best conditions that circum-
stances permit. The induction agent of
choice in an emergency is etomidate
(Hypnomidate). It has minimal respira-
tory and cardiovascular depressant
properties. An intravenous dose of 0.3
mg/kg over 30 seconds is effective in
60 seconds and has a duration of
action of 4 minutes. Involuntary muscle
movements (which will be reduced by
prior administration of a benzodi-
azepine or an opioid) and a brief
period of apnoea should be anticipat-
ed.
Other drugs used as induction agents
for intubation are propofol (Diprivan),
thiopentone, and midazolam, all of
which have disadvantages compared




This should be used unless a con-
traindication exists, in which case the
non-depolarising agent atracurium
(Tracrium) is an alternative. The
paralysing agent should be adminis-
tered only once the induction agent
has started to take effect. Suxametho-
nium is a depolarising (non-competi-
tive) agent with a rapid onset of
action which is preceded by muscle
fasciculation after a dose of 1 mg/kg
(and not one ampoule). Its duration of
action is approximately 4 minutes.
Most problems associated with its use
are related to hyperkalaemia, e.g.
burns, major trauma/crush injuries,
and severe sepsis. Caution should be
used in patients with penetrating eye
injuries because the drug raises
intraocular pressure. The first sign of
malignant hyperthermia is demonstrat-
ed by lack of masseter muscle relax-
ation after the effects of the drug
should have worn off.
Atracurium
The intubation dosage is 0.3 mg/kg,
the onset of action is 2 minutes, and
the duration of action is 15 - 30 min-
utes. The drug breaks down sponta-
neously to inactive metabolites, and
has negligible cardiovascular effects.
Histamine release occurs when high
doses (i.e. full paralysing doses) are
used. Burns patients have a relative
resistance to the drug due to low plas-
ma cholinesterase activity, so an
increased dosage is required — 0.4
mg/kg. Its action can be reversed by
neostigmine at a dose of 0.06 mg/kg
by slow intravenous bolus.
Neostigmine causes bradycardia, so
atropine should be administered con-
comitantly. As with most/all drugs the
pharmacological activity is prolonged
in hypothermic patients, so the dose
used should be reduced, e.g. 0.2
mg/kg of atracurium should be used
instead of 0.3 mg/kg.




The agents used in local anaesthesia
in emergency medicine are lidocaine
(synthetic lignocaine), prilocaine, and
bupivacaine. These are useful under
different headings:  topical, local, and
regional. 
Local anaesthetic toxicity is usually
caused by overdose or by accidental
intravascular administration. Local
anaesthetics should be used with cau-
tion in epilepsy, porphyria, and in
patients on cimetidine (which inhibits
the metabolism of these agents).
Lidocaine
The onset of action is 1 - 2 minutes,
and duration of action approximately
2 hours. Maximum dosage is 200 mg
for adults, and 3 mg/kg for children. 
• 1% lignocaine = 10 mg/ml, and
the maximum dose is 20 ml 
• 2% lignocaine = 20 mg/ml, and
the maximum dose is 10 ml. Dental
cartridges do not permit aspiration,
and contain 1.8 ml of 2% ligno-
caine. Therefore 6 cartridges con-
tain 216 mg. Lignocaine is used
mainly for local infiltration for short
procedures.
Topical skin anaesthetic agents are of
dubious use in an emergency. They do
not provide pain relief for intramuscu-
lar injections in children, but they are
of some help when only skin anaesthe-
sia is required, e.g. for intravenous
cannulation or blood sampling.
EMLA (eutectic mixture of local anaes-
thetics) cream comprises 25 mg prilo-
caine and 25 mg lignocaine. A full 60
minutes are required for adequate
effect. Amethocaine (Tetracaine)
gel/ointment (Ametop) has greater
skin penetration and takes less time to
become effective — 30 - 40 minutes.
However this preparation is not avail-
able in SA.
Mucous membranes are adequately
anaesthetised by lidocaine prepara-
tions. Remicaine jelly is available as a
2% in a 20 ml tube (400 mg/20 ml)
— 200 mg is the recommended maxi-
mum dose when anaesthetising the
male urethra for catheterisation.
Xylocaine spray delivers 10 mg of
lidocaine per spray, so 20 sprays
equals the maximum dose.
Bupivacaine (Macaine 0.5%
= 5 mg/ml)
Onset of action is up to 30 minutes.
Duration of action is 4 - 8 hours. The
maximum dose is 150 mg (30 ml of
0.5%), and 2 mg/kg for children.
Bupivacaine is used for nerve blocks
and there is now evidence to support
its use in digital blocks since 25% of
lignocaine digital nerve blocks have to
be repeated. 
Prilocaine
This is the agent of choice for regional
anaesthesia, e.g. Bier’s block. 1% =
10 mg/ml, and the maximum dose of
400 mg = 40 ml. However it is not
available as an intravenous prepara-
tion in South Africa.
In the pre-hospital arena regional
anaesthetic blocks will be used more
in the future, as people become skilled
in this practice. Practitioners of emer-
gency medicine should familiarise
themselves with the techniques associ-
ated with the common emergency
blocks — intercostal, femoral, and
haematoma blocks, as well as tech-
niques using intra-articular lidocaine
for acute anterior shoulder disloca-
tions.15 Details of these blocks are
beyond the scope of this article. There
is now an annual workshop offering
training in regional analgesia/anaes-
thesia. The next one will take place on
27 July 2004 at the University of
Cape Town  (tel. Wendy on 082-
7885759).
The use of adrenalin with
local anaesthetic agents
Adrenalin acts as a vasoconstrictor,
reduces blood loss, increases the dura-
tion of action and decreases toxicity
by delaying systemic absorption,
thereby allowing the maximum dose of
the local anaesthetic agent to be dou-
bled. Adrenalin is contraindicated
when an end-artery is involved, and in
regional anaesthesia, such as Bier’s
block. Adrenalin should be avoided in
patients with ischaemic heart disease,
hypertension, peripheral vascular dis-
ease, thyrotoxicosis, with beta blocker
usage, and in phaeochromocytoma. 
References available on request.
Keep it simple and safe.
Document times, drugs, dosages,
route of administration.
Consider local, regional, general
analgesia.
Provide analgesia first, regarding
morphine as the ‘gold standard’ in a
loading dose of 0.1 mg/kg intra-
venously, followed after 5 minutes by
aliquots of 1 - 2 mg until adequate
pain relief without any sign of respi-
ratory depression.
Monitor oxygen saturation.
Assess need for sedation — use con-
servative dose of sedative drug if
indicated.
Monitor and reassess continuously
until satisfied that the patient is com-
fortable and not compromised in any
way.
IN A NUTSHELL
